Thyroid cancer in the age of COVID-19

• Published in: Endocrine-related cancer Vol. 27; no. 11; pp. R407 - R416
• Main Authors: Tsang, Venessa H M, Gild, Matti, Glover, Anthony, Clifton-Bligh, Roderick, Robinson, Bruce G
• Format: Journal Article
• Language: English
• Published: England Bioscientifica Ltd 01.11.2020; Society for Endocrinology & BioScientifica Ltd
• Subjects: Betacoronavirus; Coronavirus Infections - epidemiology; Coronaviruses; COVID-19; Delayed Diagnosis; Disease transmission; Hospitals; Humans; Iodine Radioisotopes - therapeutic use; Pandemics; Pneumonia, Viral - epidemiology; Protein Kinase Inhibitors - therapeutic use; Review; SARS-CoV-2; Social interactions; Thyroid cancer; Thyroid Neoplasms - diagnosis; Thyroid Neoplasms - therapy; COVID-19; radioactive iodine; thyroid cancer; tyrosine kinase inhibitor

COVID-19 has modified the way we practice medicine. For thyroid cancer, there have been several significant impacts. First, the diagnosis has been delayed due to social isolation, reduced access to investigations and staff redeployment. Secondly, treatment planning has needed to take into account th...